Public filings / IMVT on Yahoo Finance (opens in a new tab)
IMVT: insider buying, 13F holders, analyst moves
Immunovant Inc - US
A summary of public filings about Immunovant Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
6 of our 100 managers hold IMVT
Combined reported value $969.9M.
Holders among our 100 managers: 5 in Q3 2023, 6 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Deep Track Capital | $359.9M | 5.30% | Trimmed |
| Farallon Capital | $223.7M | 1.31% | Added |
| Baker Bros. Advisors | $209.4M | 1.05% | Unchanged |
| RTW Investments | $122.4M | 1.04% | Unchanged |
| Perceptive Advisors | $52.3M | 0.81% | Trimmed |
| Tudor Investment | $2.2M | 0.01% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.